The outcome of an ANTI-CANCER DRUG PROGRAMME in terms of the effect on the patient's cancer.
National Codes:
1 | Complete response |
2 | Partial response |
3 | Static disease |
4 | Progressive disease |
5 | Not assessed |
6 | Unassessable |
References:
National Cancer Data Set Version 1.3_ISB October 2002
This attribute is also known by these names:
Context | Alias |
---|---|
plural | DRUG PROGRAMME RESPONSES |